Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P010014/S111

Oxford Knee System

Biomet Manufacturing Corp · Decision date Aug 7, 2025

FDA DECISIONP010014/S111

What did the FDA decide?

FDA records P010014/S111 as a supplement to PMA P010014, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Aug 7, 2025.

FDA approval order statement

reduction of Nitric biological upgrade cycle time within the nitric immersion tanks and the heated immersion rinse tanks from 600 seconds to 300 seconds, and use of an additional Biological Upgrade Line for Nitric Biological Upgrade process at the Zimmer Orthopedics Manufacturing Limited, Shannon, Ireland facility
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Orthopedic
Decision date
Aug 7, 2025
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P010014/S111
Regulatory pathway
PMA supplement
Product code
NRA
Decision code
OK30
Decision date
Aug 7, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Prosthesis, knee, femorotibial, unicompartmental, semi-constrained, metal/polymer, mobile bearing.

Product code
NRA
FDA device class
3

For the original device and its historical approval scope, see PMA P010014. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P010014 · Original PMA

    OXFORD(TM) MENISCAL UNICOMPARTMENTAL KNEE SYSTEM

  2. P010014/S111 received

    Application receipt date recorded by FDA.

  3. P010014/S109 · Related supplement

    Oxford Partial Knee System

  4. P010014/S111 · FDA decision

    30-Day Notice

  5. P010014/S113 · Related supplement

    Oxford Partial Knee System

  6. P010014/S114 · Related supplement

    Oxford Cementless Partial Knee System

  7. P010014/S115 · Related supplement

    Oxford Partial Knee System

  8. P010014/S116 · Related supplement

    Oxford Partial Knee System

  9. P010014/S112 · Related supplement

    Oxford Partial Knee System; Cementless OxfordPartial Knee System

  10. P010014/S117 · Related supplement

    Oxford Partial Knee System

  11. P010014/S118 · Related supplement

    Oxford Partial Knee Anatomic Vivacit-E Meniscal Bearings

  12. P010014/S119 · Related supplement

    Cementless Oxford Partial Knee System

  13. P010014/S120 · Related supplement

    Oxford Partial Knee System

Timeline entries are records held by MedtechLedger for P010014. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P010014

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Biomet Manufacturing Corp

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
56 E. Bell Dr.,, P.O. Box 587, Warsaw, IN, 46581

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records